Portal de Periódicos da CAPES

Clozapine for medication‐related pathological gambling in Parkinson disease

2010; Wiley; Volume: 25; Issue: 12 Linguagem: Inglês

10.1002/mds.23177

1531-8257

Alessandro Rotondo, Domenico Bosco, Massimiliano Plastino, Arturo Consoli, Francesca Bosco,

Obsessive-Compulsive Spectrum Disorders

Movement DisordersVolume 25, Issue 12 p. 1994-1995 Letter to the Editor Related to New Topics Clozapine for medication-related pathological gambling in Parkinson disease† Alessandro Rotondo MD, Alessandro Rotondo MD Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Pisa, ItalySearch for more papers by this authorDomenico Bosco MD, Corresponding Author Domenico Bosco MD [email protected] Department of Neurology, "S. Giovanni di Dio" Hospital, Via Largo Bologna, 88900 Crotone, ItalyDepartment of Neurology, "S. Giovanni di Dio" Hospital, Via Largo Bologna, 88900 Crotone, ItalySearch for more papers by this authorMassimiliano Plastino MD, Massimiliano Plastino MD Department of Neurology, "S. Giovanni di Dio" Hospital, Via Largo Bologna, 88900 Crotone, ItalySearch for more papers by this authorArturo Consoli MD, Arturo Consoli MD Department of Neuroscience, "Sapienza" University, Rome, ItalySearch for more papers by this authorFrancesca Bosco PhD, Francesca Bosco PhD Pharmacology, Course of Clinical Pharmacy, loc. Roccelletta, University, "Magna Graecia," Catanzaro, ItalySearch for more papers by this author Alessandro Rotondo MD, Alessandro Rotondo MD Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Pisa, ItalySearch for more papers by this authorDomenico Bosco MD, Corresponding Author Domenico Bosco MD [email protected] Department of Neurology, "S. Giovanni di Dio" Hospital, Via Largo Bologna, 88900 Crotone, ItalyDepartment of Neurology, "S. Giovanni di Dio" Hospital, Via Largo Bologna, 88900 Crotone, ItalySearch for more papers by this authorMassimiliano Plastino MD, Massimiliano Plastino MD Department of Neurology, "S. Giovanni di Dio" Hospital, Via Largo Bologna, 88900 Crotone, ItalySearch for more papers by this authorArturo Consoli MD, Arturo Consoli MD Department of Neuroscience, "Sapienza" University, Rome, ItalySearch for more papers by this authorFrancesca Bosco PhD, Francesca Bosco PhD Pharmacology, Course of Clinical Pharmacy, loc. Roccelletta, University, "Magna Graecia," Catanzaro, ItalySearch for more papers by this author First published: 08 September 2010 https://doi.org/10.1002/mds.23177Citations: 34 † Potential conflict of interest: The authors have no conflict of interest to disclose. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 DSM-IV-TR. Diagnostic and statistical manual of mental disorders, Fourth ed, Text Revision. Washigton, D.C. American Psychiatric Association, 2000. 2 Voon V,Fox SH. Medication-related impulse control and repetitive behaviours in Parkinson disease. Arch Neurol 2007; 64: 1089–1096. 3 Bostwick JM,Hecksel KA,Stevens SR,Bower JH,Ahlskog JE. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 2009; 84: 310–316. 4 Kurlan R. Disabling repetitive behaviours in Parkinson's disease. Mov Disord 2004; 19: 433–437. 5 Seedat S,Kesler S,Niehaus Dj,Stein DJ. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 2000; 11: 185–186. 6 Sevincok L,Akoglu A,Akyol A. Quetiapine in a case with Parkinson's disease and pathological gambling. J Clin Psychopharmacol 2007; 27: 107–108. 7 Beresford TP,Clapp L,Martin B,Wiberg JL,Alfers J,Beresford HF. Aripiprazole in schizophrenia with cocaine dependence a pilot study. J Clin Psychopharmacology 2005; 25, 363–366. 8 Connor KM,Payne VM,Gadde KM,Zhang W,Davidson JRT. The use o aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry 2005; 66: 49–51. 9 Thomas AA,Friedman JH. Current use of clozapine in Parkinson disease and related disorders. Clin Neuropharmacol 2010; 33: 14–16. 10 Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-Desmethylclozapine as a D2/D3 partial agonist. JPET 2005; 315: 1278–1287. Citing Literature Volume25, Issue1215 September 2010Pages 1994-1995 ReferencesRelatedInformation